Guided Therapeutics (GTHP) Raw Materials (2014 - 2021)

Guided Therapeutics has disclosed Raw Materials across 8 years of filings, most recently posting $1.3 million for Q1 2021.

• In Q1 2021, Raw Materials rose 63.09% year-over-year to $1.3 million; the TTM figure through Mar 2021 stood at $1.3 million (up 63.09% YoY), while the FY2020 annual figure was $1.3 million, up 63.38% from the prior year.
• Raw Materials came in at $1.3 million for Q1 2021 at Guided Therapeutics, roughly flat from $1.3 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $1.3 million in Q1 2021 to a low of $781000.0 in Q1 2019.
• Average Raw Materials over 5 years is $844294.1, with a median of $789000.0 recorded in 2017.
• Year-over-year, Raw Materials decreased 7.77% in 2017 and jumped 63.38% in 2020.
• Over 5 years, Raw Materials stood at $789000.0 in 2017, then retreated by 0.76% to $783000.0 in 2018, then slipped by 0.26% to $781000.0 in 2019, then jumped by 63.38% to $1.3 million in 2020, then climbed by 0.08% to $1.3 million in 2021.
• Per Business Quant data, the three most recent Raw Materials figures were $1.3 million in Q1 2021, $1.3 million in Q4 2020, and $782000.0 in Q3 2020.